394
Views
53
CrossRef citations to date
0
Altmetric
Original Research

SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer

, , , , , , , , , , , , , , , , , , , , , & show all
Pages 6165-6178 | Published online: 02 Aug 2019

References

  • WHO. Guide to cancer early diagnosis; 2017 Available from: http://www.who.int/cancer/publications/cancer_early_diagnosis/en/, 2018.
  • Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review. 1975–2014; 2018 Available from: https://seer.cancer.gov/csr/1975_2014/. Accessed June 27, 2019.
  • Robinson DR, Wu YM, Lonigro RJ, et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548(7667):297–303. doi:10.1038/nature2300428783718
  • Andriole GL, Crawford ED, Grubb RL 3rd, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104(2):125–132. doi:10.1093/jnci/djr50022228146
  • Keating NL, Pace LE. Breast cancer screening in 2018: Time for shared decision making. JAMA. 2018;319(17):1814–1815.  
  • US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.JAMA. 2016;315(23):2564–2575.
  • Moyer VA, US Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160(5):330–338.
  • US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for ovarian cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(6):588-594.
  • Moyer VA, US Preventive Services Task Force. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(1):55–60.
  • Phallen J, Sausen M, Adleff V, et al. Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. 2017;9:403. doi:10.1126/scitranslmed.aan2415
  • Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res. 2009;15(2):431–440. doi:10.1158/1078-0432.CCR-08-105919147747
  • Fuzery AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics. 2013;10(1):13. doi:10.1186/1559-0275-10-1724088261
  • Zong C, Xu M, Xu L-J, et al. Surface-enhanced raman spectroscopy for bioanalysis: reliability and challenges. Chem Rev. 2018;118(10):4946–4980. doi:10.1021/acs.chemrev.7b0066829638112
  • Jafarzadeh N, Mani-Varnosfaderani A, Gilany K, Eynali S, Ghaznavi H, Shakeri-Zadeh A. The molecular cues for the biological effects of ionizing radiation dose and post-irradiation time on human breast cancer SKBR3 cell line: A Raman spectroscopy study. J Photochem Photobiol B. 2018;180:1–8. doi:10.1016/j.jphotobiol.2018.01.01429413692
  • Sha MY, Xu H, Penn SG, Cromer R. SERS nanoparticles: a new optical detection modality for cancer diagnosis. Nanomedicine (Lond). 2007;2(5):725–734. doi:10.2217/17435889.2.5.72517976033
  • Zhang Y, Hong H, Myklejord DV, Cai W. Molecular imaging with SERS-active nanoparticles. Small. 2011;7(23):3261–3269. doi:10.1002/smll.20110059721932216
  • Hossain MK, Kitahama Y, Huang GG, Han X, Ozaki Y. Surface-enhanced Raman scattering: realization of localized surface plasmon resonance using unique substrates and methods. Anal Bioanal Chem. 2009;394(7):1747–1760. doi:10.1007/s00216-009-2762-419384546
  • Birke RL, Lombardi JR, Saidi WA, Norman P. Surface-enhanced Raman scattering due to charge-transfer resonances: a time-dependent density functional theory study of Ag13-4-mercaptopyridine. J Phys Chem C. 2016;120(37):20721–20735. doi:10.1021/acs.jpcc.6b01961
  • Wan F, Shi H, Chen W, et al. Charge transfer effect on raman and surface enhanced raman spectroscopy of furfural molecules. Nanomaterials. 2017;7(8):210. doi:10.3390/nano7120458
  • Campion A, Ivanecky JE, Child CM, Foster M. On the mechanism of chemical enhancement in surface-enhanced Raman scattering. J Am Chem Soc. 1995;117(47):11807–11808. doi:10.1021/ja00152a024
  • Bilal M, Bilal M, Tabassum S, et al. Optical screening of female breast cancer from whole blood using raman spectroscopy. Appl Spectrosc. 2017;71(5):1004–1013. doi:10.1177/000370281666751627634888
  • Bhattacharjee T, Khan A, Kumar P, Ingle A, Maru G, Krishna CM. Raman spectroscopy of serum: A study on ‘pre’ and ‘post’ breast adenocarcinoma resection in rat models. J Biophotonics. 2015;8(7):575–583. doi:10.1002/jbio.20140004025044732
  • Cervo S, Mansutti E, Del Mistro G, et al. SERS analysis of serum for detection of early and locally advanced breast cancer. Anal Bioanal Chem. 2015;407(24):7503–7509. doi:10.1007/s00216-015-8923-826255294
  • Wang H, Zhang S, Wan L, Sun H, Tan J, Su Q. Screening and staging for non-small cell lung cancer by serum laser Raman spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc. 2018;201:34–38. doi:10.1016/j.saa.2018.04.00229729529
  • Ullah I, Ahmad I, Nisar H, et al. Computer assisted optical screening of human ovarian cancer using Raman spectroscopy. Photodiagnosis Photodyn Ther. 2016;15:94–99. doi:10.1016/j.pdpdt.2016.05.01127238739
  • Lin D, Huang H, Qiu S, Feng S, Chen G, Chen R. Diagnostic potential of polarized surface enhanced Raman spectroscopy technology for colorectal cancer detection. Opt Express. 2016;24(3):2222–2234. doi:10.1364/OE.24.00222226906798
  • Feng S, Wang W, Tai IT, Chen G, Chen R, Zeng H. Label-free surface-enhanced Raman spectroscopy for detection of colorectal cancer and precursor lesions using blood plasma. Biomed Opt Express. 2015;6(9):3494–3502. doi:10.1364/BOE.6.00349426417518
  • Jenkins CA, Lewis PD, Dunstan PR, Harris DA. Role of Raman spectroscopy and surface enhanced Raman spectroscopy in colorectal cancer. World J Gastrointest Oncol. 2016;8(5):427–438. doi:10.4251/wjgo.v8.i5.42727190582
  • Sahu A, Sawant S, Mamgain H, Krishna CM. Raman spectroscopy of serum: an exploratory study for detection of oral cancers. Analyst. 2013;138(14):4161–4174. doi:10.1039/c3an00308f23736856
  • Xiao R, Zhang X, Rong Z, et al. Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopy. Nanomedicine. 2016;12(8):2475–2484. doi:10.1016/j.nano.2016.07.01427520725
  • Leopold N, Lendl B. A New Method for Fast Preparation of Highly Surface-Enhanced Raman Scattering (SERS) Active Silver Colloids at Room Temperature by Reduction of Silver Nitrate with Hydroxylamine Hydrochloride. J Phys Chem B 2003;107(24):5723–5727.
  • Bonifacio A, Dalla Marta S, Spizzo R, et al. Surface-enhanced Raman spectroscopy of blood plasma and serum using Ag and Au nanoparticles: a systematic study. Anal Bioanal Chem. 2014;406(9–10):2355–2365. doi:10.1007/s00216-014-7622-124493335
  • Westley C, Xu Y, Thilaganathan B, Carnell AJ, Turner NJ, Goodacre R. Absolute quantification of uric acid in human urine using surface enhanced Raman scattering with the standard addition method. Anal Chem. 2017;89(4):2472–2477.28192933
  • Westley C, Xu Y, Carnell AJ, Turner NJ, Goodacre R. Label-free surface enhanced Raman scattering approach for high-throughput screening of biocatalysts. Anal Chem. 2016;88(11):5898–5903. doi:10.1021/acs.analchem.6b0081327132981
  • Jenkins CA, Jenkins RA, Pryse MM, et al. A high-throughput serum Raman spectroscopy platform and methodology for colorectal cancer diagnostics. Analyst. 2018;143(24):6014–6024. doi:10.1039/c8an01323c30398225
  • Smith TA. Carotenoids and cancer: prevention and potential therapy. Br J Biomed Sci. 1998;55(4):268–275.10436544
  • Bonifacio A, Cervo S, Sergo V. Label-free surface-enhanced Raman spectroscopy of biofluids: fundamental aspects and diagnostic applications. Anal Bioanal Chem. 2015;407(27):8265–8277. doi:10.1007/s00216-015-8697-z25935674
  • Toniolo P, Van Kappel AL, Akhmedkhanov A, et al. Serum carotenoids and breast cancer. Am J Epidemiol. 2001;153(12):1142–1147. doi:10.1093/aje/153.12.114211415946
  • Huang J, Lu MS, Fang YJ, et al. Serum carotenoids and colorectal cancer risk: A case-control study in Guangdong, China. Mol Nutr Food Res. 2017;61:10. doi:10.1002/mnfr.201700267
  • Abar L, Vieira AR, Aune D, et al. Blood concentrations of carotenoids and retinol and lung cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Cancer Med. 2016;5(8):2069–2083. doi:10.1002/cam4.67627384231
  • Chippagiri P, Im A, Banavar SR. Role of serum ß-carotene in the diagnosis and prevention of oral squamous cell carcinoma - a case control study. J Clin Diagn Res. 2014;8(4):ZC01–ZC03. doi:10.7860/JCDR/2014/7534.4211
  • Jeong NH, Song ES, Lee JM, et al. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta Obstet Gynecol Scand. 2009;88(4):457–462. doi:10.1080/0001634090280721519266359
  • McCartney A, Vignoli A, Biganzoli L, et al. Metabolomics in breast cancer: a decade in review. Cancer Treat Rev. 2018;67:88–96. doi:10.1016/j.ctrv.2018.04.01229775779
  • Erben V, Bhardwaj M, Schrotz-King P, Brenner H. Metabolomics biomarkers for detection of colorectal neoplasms: a systematic review. Cancers. 2018;10(8):246. doi:10.3390/cancers10110400
  • Yu L, Li K, Zhang X. Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review. Oncotarget. 2017;8(70):115774–115786. doi:10.18632/oncotarget.2240429383200
  • Turkoglu O, Zeb A, Graham S, et al. Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature. Metabolomics. 2016;12:4. doi:10.1007/s11306-016-0990-0
  • Shin JM, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Metabolomics of head and neck cancer: a mini-review. Front Physiol. 2016;7:526. doi:10.3389/fphys.2016.0052627877135
  • McGregor HC, Short MA, Lam S, Shaipanich T, Beaudoin EL, Zeng H. Development and in vivo test of a miniature Raman probe for early cancer detection in the peripheral lung. J Biophotonics. 2018;11(11):e201800055. doi:10.1002/jbio.20170039330079507
  • Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med. 2014;371(8):757–765. doi:10.1056/NEJMra130391725140961
  • Stefancu A, Moisoiu V, Couti R, et al. Combining SERS analysis of serum with PSA levels for improving the detection of prostate cancer. Nanomedicine (Lond). 2018;13(19):2455–2467. doi:10.2217/nnm-2018-012730284481
  • Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer. 2006;107(3):459–466. doi:10.1002/cncr.2203516795065
  • Tu Q, Chang C. Diagnostic applications of Raman spectroscopy. Nanomedicine. 2012;8(5):545–558. doi:10.1016/j.nano.2011.09.01322024196
  • Mosier-Boss PA. Review of SERS Substrates for Chemical Sensing. Nanomaterials (Basel). 2017;7(6):142. doi:10.3390/nano7120458